Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron

Journal of Pharmaceutical Sciences

Volumn 101, Issue 12, 2012, Pages 4540-4548

  Sun, Lin ^a   Cun, Dongmei ^a   Yuan, Bo ^a   Cui, Hongxia ^a   Xi, Honglei ^a   Mu, Liwei ^a   Chen, Yang ^a   Liu, Chao ^a   Wang, Zhongyan ^a   Fang, Liang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Azasetron; Bama miniature pig; Deconvolution; Drug delivery systems; In vitro in vivo correlations (IVIVC); Percutaneous; Pharmacokinetics; Skin; Transdermal

Indexed keywords

EID: 84868215045     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23317     Document Type: Article

References (20)

1. Viale PH. 2005. Integrating aprepitant and palonosetron into clinical practice: A role for the new antiemetics. Clin J Oncol Nurs 9:77-84.
2. Jordan K, Schmoll HJ, Aapro MS. 2007. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol 61:162-175.
3. 3 receptors on colonic transit in rats. Obes Res 3:801S-810S.
4. Yun MJ, Kim YH, Kim AR. 2010. Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery. Yonsei Med J 51:88-92.
5. Haga K, Inaba K, Shoji H, Morimoto Y, Fukuda T, Setoguchi M. 1993. The effects of orally administered Y-25130, a selective serotonin 3-receptor antagonist, on chemotherapeutic agent-induced emesis. Jpn J Pharmacol 63:377-383.
6. Sakamori M, Takehara S, Setoguchi M. 1992. High affinity binding of Y-25130 for serotonin 3 receptor. Nippon Yakurigaku Zasshi 100:137-142.
7. Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM, on behalf of the Sancuso Study Group. 2010. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: A randomized, double-blind, phase III study. Support Care Cancer 19:1609-1617.
8. Duggan ST, Curran MP. 2009. Transdermal granisetron. Drugs 69:2597-2605.
9. Xi H, Yang Y, Zhao D, Fang L, Sun L, Mu L, Liu J, Zhao N, Zhao Y, Zheng N, He Z. 2010. Transdermal patches for site-specific delivery of anastrozole: in vitro and local tissue disposition evaluation. Int J Pharm 391:73-78.
10. Agrawala P, Ritschel WA. 1988. Influence of 1-dodecylhexahydro-2H-azepin-2-one (Azone) on the in vitro permeation of verapamil hydrochloride across rat, hairless mouse, and human cadaver skin. J Pharm Sci 77:776-778.
11. Valiverti S, Hammell DC, Paudel IS, Hamad MO, Crooks PA, Stinchcomb AL. 2005. in vivo evaluation of 3-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs. J Control Release 102:509-520.
12. Tan HS, Pfister WR. 1999. Pressure-sensitive adhesives for transdermal drug delivery systems. Pharm Sci Technol Today 2:60-69.
13. Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv 56:603-618.
14. Leopold CS, Maibach HI. 1996. Effect of lipophilic vehicles on in vivo skin permeation of methyl nicotinate in different races. Int J Pharm 139:161-167.
15. Gorukanti SR, Li L, Kim KH. 1999. Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int J Pharm 192:159-172.
16. Sun Y, Fang L, Zhu M, Li W, Meng P, Li L, He Z. 2009. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization. Int J Pharm 382:165-171.
17. Lee PJ, Ahmad N, Langer R, Mitragotri S, Shastri VP. 2006. Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm 308:33-39.
18. Barbero AM, Frasch HF. 2009. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicol in vitro 23:1-13.
19. Frost AB, Larsen F, Ostergaard J, Larsen SW, Lindegaard C, Hansen HR, Larsen C. 2010. On the search for in vitro in vivo correlations in the field of intra-articular drug delivery: Administration of sodium diatrizoate to the horse. Eur J Pharm Sci 41:10-15.
20. Qi X, Liu RR, Sun D, Ackermann C, Hou H. 2003. Convolution method to predict drug concentration profiles of 2, 3, 5, 6-tetramethylpyrazine following transdermal application. Int J Pharm 259:39-45.